Medicare Enrolled
Dr. Susane Habashi-Ahigian, M.D.
Family Medicine · Denver, NC
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Habashi-Ahigian from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Habashi-Ahigian?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Habashi-Ahigian
Dr. Susane Habashi-Ahigian is a family medicine specialist in Denver, NC, with 20 years of NPI registration. Based on federal Medicare data, Dr. Habashi-Ahigian performed 782 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Habashi-Ahigian received a total of $14,629 from 72 pharmaceutical and/or device companies across 828 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Habashi-Ahigian is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 37% volume in NC
$14,629 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗782
Medicare services
Top 37% in NC for family medicine
Not available
Unique patients (not deduplicated)
$52
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
254 | $89 | $138 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
243 | $63 | $97 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
149 | $0 | $22 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
53 | $1 | $7 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
32 | $3 | $17 |
| Drug test with direct observation A drug screening test performed under direct observation to ensure the sample is provided correctly. This method is used to verify the integrity of the specimen collection process. |
23 | $12 | $25 |
| COVID-19 immunoassay detection test A laboratory test that uses an immunoassay method to detect the presence of severe acute respiratory syndrome coronavirus 2 (COVID-19) through direct visual observation. |
14 | $41 | $60 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
14 | $130 | $236 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
1.8% high complexity
25.8% medium
72.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$14,629
Total received (2018-2024)
Avg $2,090/year across 7 years
Top 2% in NC for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
72
Companies
828
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,675
2023
$2,202
2022
$2,234
2021
$2,434
2020
$2,234
2019
$1,847
2018
$2,003
Payments by company (2024)
Novo Nordisk Inc
$207
Antares Pharma, Inc.
$176
Bayer Healthcare Pharmaceuticals Inc.
$172
Lilly USA, LLC
$133
Esperion Therapeutics, Inc.
$106
Mannkind Corporation
$105
AstraZeneca Pharmaceuticals LP
$91
Janssen Pharmaceuticals, Inc
$83
Renalytix AI, Inc.
$76
Boehringer Ingelheim Pharmaceuticals, Inc.
$75
Amneal Pharmaceuticals LLC
$62
Amgen Inc.
$57
Tolmar, Inc.
$54
Abbott Laboratories
$49
Astellas Pharma US Inc
$47
Azurity Pharmaceuticals, Inc.
$46
ABBVIE INC.
$40
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$33
Phathom Pharmaceuticals, Inc.
$27
Almatica Pharma LLC
$21
Kowa Pharmaceuticals America, Inc.
$15
Top 3 companies account for 33.1% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$1,406
Novo Nordisk Inc
$1,173
PFIZER INC.
$936
Janssen Pharmaceuticals, Inc
$875
Boehringer Ingelheim Pharmaceuticals, Inc.
$854
Amarin Pharma Inc.
$711
Lilly USA, LLC
$643
GlaxoSmithKline, LLC.
$589
Kowa Pharmaceuticals America, Inc.
$531
Paratek Pharmaceuticals, Inc.
$472
Amgen Inc.
$458
Bayer Healthcare Pharmaceuticals Inc.
$391
Esperion Therapeutics, Inc.
$346
SANOFI-AVENTIS U.S. LLC
$318
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$316
Merck Sharp & Dohme Corporation
$315
ARBOR PHARMACEUTICALS, INC.
$283
Amneal Pharmaceuticals LLC
$272
Mannkind Corporation
$259
Clarus Therapeutics Inc.
$246
Takeda Pharmaceuticals U.S.A., Inc.
$216
MannKind Corporation
$215
Novartis Pharmaceuticals Corporation
$210
Abbott Laboratories
$189
Azurity Pharmaceuticals, Inc.
$189
Antares Pharma, Inc.
$176
IBSA Pharma Inc.
$162
IDORSIA PHARMACEUTICALS US INC
$158
Bayer HealthCare Pharmaceuticals Inc.
$150
AbbVie, Inc.
$103
AbbVie Inc.
$92
Biohaven Pharmaceutical Holding Company Ltd.
$89
ABBVIE INC.
$84
Tolmar, Inc.
$84
Renalytix AI, Inc.
$76
Arbor Pharmaceuticals, Inc.
$75
Merck Sharp & Dohme LLC
$71
Astellas Pharma US Inc
$67
SANOFI PASTEUR INC.
$67
Nestle HealthCare Nutrition Inc.
$56
Phathom Pharmaceuticals, Inc.
$51
Romark Laboratories, LC
$46
Phadia US Inc.
$45
Hikma Pharmaceuticals USA
$36
Aytu BioScience, Inc
$33
Almatica Pharma LLC
$33
Lupin Inc.
$29
Intercept Pharmaceuticals, Inc.
$29
Acella Pharmaceuticals, LLC
$29
E.R. Squibb & Sons, L.L.C.
$27
Allergan Inc.
$27
ARALEZ PHARMACEUTICALS US INC.
$26
Sumitomo Pharma America, Inc.
$21
Dexcom, Inc.
$21
Eisai Inc.
$17
Currax Pharmaceuticals LLC
$16
DEXCOM, INC.
$16
FORTE BIO-PHARMA LLC
$16
VistaPharm, Inc.
$15
Zyla Life Sciences, Inc.
$15
BOSTON SCIENTIFIC CORPORATION
$15
NESTLE HEALTHCARE NUTRITION INC.
$15
EISAI INC.
$15
Assertio Therapeutics, Inc.
$14
Gemini Laboratories, LLC
$14
Flexion Therapeutics, Inc.
$13
Aytu BioPharma, Inc.
$13
Allergan, Inc.
$13
Preventice Services, LLC
$12
OptiNose US, Inc.
$12
Purdue Pharma L.P.
$11
Acerus Pharmaceuticals Corporation
$11
Top 3 companies account for 24.0% of all-time payments
Associated products mentioned in payments ›
AFREZZA · ANORO · ANORO ELLIPTA · Adthyza · Aimovig · Alinia · Androgel · BELSOMRA · BEVESPI AEROSPHERE · BEXSERO · BG Mini Plus · BOTOX COSMETIC · BREO · BREZTRI · BREZTRI AEROSPHERE · Belviq · CHANTIX · COMIRNATY · CONTRAVE · DEXCOM G6 TRANSMITTER · Dayvigo · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · Edarbi · Edarbyclor · FARXIGA · FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre 2 · GEMTESA · GENERAL PAIN MANAGEMENT · GLYXAMBI · GRALISE · HORIZANT · Horizant · ImmunoCAP · JANUVIA · JARDIANCE · JATENZO · KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT · Kerendia · LINZESS · LIVALO · LOREEV XR · LYRICA · Licart · Livalo · MOUNJARO · Mitigare · NEXLETOL · NEXLIZET · NP Thyroid · NP Thyroid 60 · NURTEC ODT · NUZYRA · Natesto · OCALIVA · Otezla · Ozempic · PAXLOVID · PROLATE · QUVIVIQ · RYBELSUS · Repatha · Rybelsus · SEGLENTIS · SHINGRIX · SIVEXTRO · SOLIQUA · SOLIQUA 100/33 · SOLOSEC · SPRIX · STIOLTO RESPIMAT · SUPRAX · SYMBICORT · SYMPROIC · SYNTHROID · Saxenda · Synthroid · TAGRISSO · TOUJEO · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · Thyquidity · Tirosint · Tresiba · Trintellix · UBRELVY · UNITHROID · Uloric · V-GO · VAXELIS · VIIBRYD · VOQUEZNA · VRAYLAR · VYVANSE · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XIFAXAN · XIGDUO · XYOSTED · Xhance · ZENPEP · ZEPBOUND · ZIPSOR · ZONTIVITY · Zilretta
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Family medicine physicians in nearby ZIP areas
545
County median income
$78,490
Nearest hospital to ZIP centroid (approximate)
DUKE HEALTH LAKE NORMAN HOSPITAL
8.9 mi
8.9 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Habashi-Ahigian is a clinical cardiology specialist, with moderate Medicare volume, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Habashi-Ahigian experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Habashi-Ahigian performed 254 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Habashi-Ahigian receive payments from pharmaceutical companies?
Yes. Dr. Habashi-Ahigian received a total of $14,629 from 72 companies across 828 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Habashi-Ahigian's costs compare to other family medicine physicians in Denver?
Dr. Habashi-Ahigian's average Medicare payment per service is $52. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Habashi-Ahigian) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Denver
Browse family medicine physicians in Denver ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in NC
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in NC
Which NC family medicine physicians receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology